This archive contains the following articles listed by volume, issue and page number:
 |
|
|
PAIN MANAGEMENT RELATED ARTICLES |
Title (Click for Details) |
Vol/Issue |
Page |
NASEM Report on Compounded Topical Pain Creams |
Vol. 24 No. 6 |
446 |
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection
(Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection
(Vet-Mouse) |
Vol. 24 No. 5 |
406 |
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream |
Vol. 24 No. 4 |
313 |
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) |
Vol. 24 No. 4 |
320 |
Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4 |
Vol. 24 No. 4 |
321 |
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4 |
Vol. 24 No. 4 |
327 |
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality |
Vol. 24 No. 3 |
194 |
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules |
Vol. 24 No. 3 |
227 |
Topiramate 5 mg/mL in SyrSpend SF pH4 |
Vol. 24 No. 2 |
138 |
Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia |
Vol. 24 No. 2 |
156 |
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension |
Vol. 23 No. 6 |
486 |
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? |
Vol. 23 No. 6 |
496 |
Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes |
Vol. 23 No. 4 |
318 |
Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation |
Vol. 23 No. 3 |
250 |
Acetaminophen 50% Pluronic Lecithin Organogel Gel |
Vol. 23 No. 2 |
146 |
Ketoprofen 10% in Pluronic Lecithin Organogel |
Vol. 23 No. 2 |
150 |
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 |
Vol. 23 No. 1 |
14 |
Ketoprofen 10% in Pluronic Lecithin Organogel |
Vol. 23 No. 1 |
52 |
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension |
Vol. 23 No. 1 |
53 |
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes |
Vol. 23 No. 1 |
54 |
Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream |
Vol. 23 No. 1 |
82 |
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin |
Vol. 22 No. 6 |
498 |
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 |
Vol. 22 No. 4 |
284 |
Ketoprofen 10% in Pluronic Lecithin Organogel |
Vol. 22 No. 4 |
319 |
Kinetics of Tetracaine Solvolysis in Propylene Glycol |
Vol. 22 No. 4 |
329 |
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension |
Vol. 22 No. 3 |
235 |
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia |
Vol. 22 No. 3 |
252 |
Prochlorperazine Edisylate 0.5% Nasal Spray |
Vol. 22 No. 2 |
150 |
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome |
Vol. 22 No. 2 |
172 |
Pain: Systematic Review of Pharmacy Compounding of Pain Medication |
Vol. 22 No. 1 |
19 |
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF |
Vol. 22 No. 1 |
54 |
Tolmetin 400-mg Capsules |
Vol. 21 No. 6 |
497 |
Compounding Opportunities in Urology |
Vol. 21 No. 5 |
358 |
Fentanyl Citrate 50-mcg/mL Injection |
Vol. 21 No. 5 |
411 |
Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel |
Vol. 21 No. 4 |
314 |
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia |
Vol. 21 No. 4 |
347 |
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base |
Vol. 21 No. 3 |
234 |
Meloxicam 1% Topical Gel |
Vol. 21 No. 3 |
235 |
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs |
Vol. 21 No. 2 |
164 |
Nifedipine 0.5% Rectal Ointment |
Vol. 21 No. 1 |
63 |
Tetracaine Hydrochloride 0.5% Ophthalmic Solution |
Vol. 21 No. 1 |
64 |
Calculations |
Vol. 20 No. 6 |
502 |
Capsaicin 0.025% and Doxepin 3.3% Cream |
Vol. 20 No. 6 |
506 |
Melatonin 2-mg/mL Oral Suspension |
Vol. 20 No. 6 |
512 |
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment |
Vol. 20 No. 6 |
513 |
Stability of Fentanyl Citrate in Polyolefin Bags |
Vol. 20 No. 6 |
514 |
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial |
Vol. 20 No. 6 |
517 |
Naproxen 5% Cream |
Vol. 20 No. 5 |
410 |
Tetracaine Hydrochloride 2% Topical Solution |
Vol. 20 No. 5 |
414 |
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients |
Vol. 20 No. 3 |
197 |
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm |
Vol. 20 No. 3 |
231 |
Pain-Away II Headache Capsules |
Vol. 20 No. 3 |
233 |
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children |
Vol. 20 No. 3 |
247 |
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives |
Vol. 20 No. 3 |
250 |
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future |
Vol. 20 No. 2 |
107 |
Blue Goo Anti-Itch Gel |
Vol. 20 No. 2 |
144 |
Medicated Polyox Bandage for Skin Ulcers |
Vol. 20 No. 2 |
146 |
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray |
Vol. 20 No. 2 |
147 |
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm |
Vol. 20 No. 1 |
50 |
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules |
Vol. 19 No. 6 |
504 |
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review |
Vol. 19 No. 4 |
295 |
Proparacaine Hydrochloride 0.5% Ophthalmic Solution |
Vol. 19 No. 4 |
332 |
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution |
Vol. 19 No. 3 |
243 |
Phenazopyridine Hydrochloride 200-mg Capsules |
Vol. 19 No. 3 |
245 |
Physostigmine Salicylate 1-mg/mL Injection |
Vol. 19 No. 3 |
246 |
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles |
Vol. 19 No. 3 |
268 |
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution |
Vol. 19 No. 2 |
148 |
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations |
Vol. 19 No. 2 |
161 |
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time |
Vol. 19 No. 2 |
167 |
Lidocaine Hydrochloride 4% Topical Solution |
Vol. 19 No. 1 |
67 |
Skin Penetration and Antinociception of Topical Gabapentin Formulations |
Vol. 18 No. 6 |
504 |
Sumatriptan Succinate 12-mg/mL Injection |
Vol. 18 No. 5 |
416 |
Compounded Pain Formulations: What is the Evidence? |
Vol. 18 No. 4 |
278 |
Atracurium Besylate 10-mg/mL Injection, Preserved |
Vol. 18 No. 4 |
322 |
Choline Magnesium Trisalicylate Liquid |
Vol. 18 No. 4 |
327 |
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications |
Vol. 18 No. 3 |
182 |
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice |
Vol. 18 No. 3 |
190 |
Bupivacaine Hydrochloride 0.5% Injection |
Vol. 18 No. 3 |
234 |
Butorphanol Tartrate 10-mg/mL Nasal Spray |
Vol. 18 No. 3 |
235 |
Dibucaine 1% Ointment |
Vol. 18 No. 3 |
236 |
Lidocaine Hydrochloride 1% Injection |
Vol. 18 No. 3 |
237 |
Naproxen 25-mg/mL Oral Suspension |
Vol. 18 No. 3 |
239 |
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery |
Vol. 18 No. 3 |
256 |
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report |
Vol. 18 No. 1 |
14 |
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C |
Vol. 18 No. 1 |
78 |
Dihydroergotamine Mesylate 1-mg/mL Injection |
Vol. 17 No. 6 |
503 |
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles |
Vol. 17 No. 6 |
508 |
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream |
Vol. 17 No. 6 |
520 |
Indomethacin 1-mg/mL Injection |
Vol. 17 No. 5 |
419 |
Ketamine 50-mg/mL Injection |
Vol. 17 No. 4 |
331 |
Methohexital Sodium 500-mg/mL Injection |
Vol. 17 No. 4 |
332 |
Buffered Aspirin Capsules |
Vol. 17 No. 3 |
228 |
Naltrexone Hydrochloride 50-mg Capsules |
Vol. 17 No. 3 |
235 |
Alcohol Dehydrated Injection |
Vol. 17 No. 2 |
145 |
Ibuprofen 10-mg/mL Injection |
Vol. 17 No. 1 |
67 |
Mepivacaine Hydrochloride 1% Injection |
Vol. 17 No. 1 |
68 |
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act |
Vol. 16 No. 6 |
446 |
Palliative Care and Compounding for Household Pets |
Vol. 16 No. 6 |
452 |
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents |
Vol. 16 No. 6 |
462 |
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules |
Vol. 16 No. 6 |
506 |
Vercuronium Bromide 1-mg/mL Injection |
Vol. 16 No. 6 |
509 |
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report |
Vol. 16 No. 5 |
364 |
Meperidine Hydrochloride 50-mg/mL Injection |
Vol. 16 No. 5 |
423 |
Methocarbamol 100-mg/mL Injection |
Vol. 16 No. 5 |
424 |
Nalbuphine Hydrochloride 10-mg/mL Injection |
Vol. 16 No. 5 |
426 |
Oxymorphone Hydrochloride 1-mg/mL Injection |
Vol. 16 No. 5 |
427 |
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date |
Vol. 16 No. 5 |
428 |
A Concise Discussion of Headache Types, Part 3: Migraine |
Vol. 16 No. 4 |
270 |
Butorphanol Tartrate 2-mg/mL Injection |
Vol. 16 No. 4 |
333 |
Ketorolac Tromethamine 15-mg/mL Injection |
Vol. 16 No. 4 |
337 |
Sufentanil Citrate 50-mcg/mL Injection |
Vol. 16 No. 4 |
340 |
A Concise Discussion of Headache Types, Part 2: Migraine |
Vol. 16 No. 3 |
182 |
Burning Mouth Syndrome: A Discussion of a Complex Pathology |
Vol. 16 No. 3 |
196 |
Alfentanil 500-mcg/mL Injection |
Vol. 16 No. 3 |
239 |
A Concise Discussion of Headache Types, Part 1 |
Vol. 16 No. 2 |
125 |
Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection |
Vol. 16 No. 2 |
155 |
Caffeine Citrate 20-mg/mL Injection |
Vol. 16 No. 2 |
156 |
Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method |
Vol. 16 No. 2 |
170 |
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management |
Vol. 16 No. 1 |
22 |
Case Studies of Compounded Tramadol Use in Cats |
Vol. 16 No. 1 |
44 |
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion |
Vol. 15 No. 6 |
504 |
Magic Mouthwashes: A Literature Review and Discussion of Common Compositions |
Vol. 15 No. 5 |
376 |
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient |
Vol. 15 No. 5 |
386 |
Transdermals: The Skin as Part of a Drug Delivery System |
Vol. 15 No. 4 |
308 |
Anesthetic Nasal Ointment |
Vol. 15 No. 4 |
334 |
Oxandrolone 1-mg/mL Oral Suspension |
Vol. 15 No. 4 |
341 |
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient |
Vol. 15 No. 3 |
194 |
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel |
Vol. 15 No. 3 |
242 |
Diclofenac Sodium 1% Topical Gel |
Vol. 15 No. 3 |
243 |
Ibuprofen 5% Topical Cream |
Vol. 15 No. 3 |
244 |
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel |
Vol. 15 No. 3 |
245 |
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel |
Vol. 15 No. 2 |
157 |
PostScription: Commentary: Discussion on the Safety of Topical Prilocaine |
Vol. 15 No. 2 |
174 |
Current Concepts in the Treatment of Recurrent Aphthous Ulcers |
Vol. 15 No. 1 |
13 |
Toxicities Associated with Topical Anesthetics |
Vol. 15 No. 1 |
41 |
Diclofenac Sodium 10-mg/mL Oral Suspension |
Vol. 15 No. 1 |
64 |
Ibuprofen 5% Gel |
Vol. 15 No. 1 |
66 |
Piroxicam 1% Gel |
Vol. 15 No. 1 |
69 |
Pramoxine 1% Cream |
Vol. 15 No. 1 |
70 |
All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding |
Vol. 14 No. 6 |
484 |
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
512 |
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
513 |
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
514 |
Capsaicin 0.05% Clear Medication Stick |
Vol. 14 No. 6 |
517 |
Ketoprofen 2% Oral Gel |
Vol. 14 No. 6 |
521 |
"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care |
Vol. 14 No. 6 |
480 |
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel |
Vol. 14 No. 6 |
520 |
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients |
Vol. 14 No. 5 |
395 |
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection |
Vol. 14 No. 5 |
427 |
Polidocanol 0.5% Wound Spray |
Vol. 14 No. 5 |
429 |
Acyclovir with Benzocaine Lip Balm |
Vol. 14 No. 4 |
332 |
Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone |
Vol. 14 No. 4 |
333 |
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser |
Vol. 14 No. 4 |
310 |
Buprenorphine Hydrochloride Injection |
Vol. 14 No. 4 |
337 |
Chloroprocaine Hydrochloride Injection |
Vol. 14 No. 4 |
338 |
Flurbiprofen 5% Bioadhesive Gel for Gingivitis |
Vol. 14 No. 4 |
341 |
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome |
Vol. 14 No. 3 |
182 |
Topical Medications for Orofacial Neuropathic Pain |
Vol. 14 No. 3 |
200 |
Managing Pain with Transdermal Ketoprofen |
Vol. 14 No. 3 |
204 |
Potential Treatments for Radiation Dermatitis |
Vol. 14 No. 3 |
210 |
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report |
Vol. 14 No. 3 |
215 |
Calculations |
Vol. 14 No. 3 |
230 |
Carprofen 2.5-mg/mL Oral Suspension, Veterinary |
Vol. 14 No. 3 |
241 |
Celecoxib 10-mg/mL Oral Suspension |
Vol. 14 No. 3 |
242 |
The Role of Sex Hormones on Fibromyalgia Pain Mediators |
Vol. 14 No. 3 |
193 |
Cohen's Rectal Ointment |
Vol. 14 No. 3 |
244 |
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector |
Vol. 14 No. 2 |
160 |
Tetracaine 4% and Menthol 5% Topical Gel |
Vol. 14 No. 1 |
73 |
Trigger Point Gel |
Vol. 14 No. 1 |
75 |
Topiramate 6-mg/mL Oral Suspension |
Vol. 13 No. 6 |
560 |
Aceclofenac 1.5% Pluronic Lecithin Organogel |
Vol. 13 No. 5 |
428 |
An Abridged History of Aspirin |
Vol. 13 No. 5 |
404 |
Lidocaine 10% Oral Pluronic Lecithin Organogel |
Vol. 13 No. 5 |
433 |
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications |
Vol. 13 No. 5 |
400 |
Update on Managing Neuropathic Pain |
Vol. 13 No. 3 |
182 |
Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids |
Vol. 13 No. 3 |
192 |
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report |
Vol. 13 No. 3 |
196 |
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers |
Vol. 13 No. 3 |
214 |
Safe Use of Topical Local Anesthetic Medications for Pain Management |
Vol. 13 No. 3 |
218 |
Calculations |
Vol. 13 No. 3 |
239 |
Analgesic Compound Lotion, Clear |
Vol. 13 No. 3 |
240 |
Hydromorphone Hydrochloride 10-mg/mL Oral Drops |
Vol. 13 No. 3 |
241 |
Lidocaine 2% Popsicle |
Vol. 13 No. 3 |
242 |
Morphine Sulfate 10-mg/mL Oral Solution |
Vol. 13 No. 3 |
243 |
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel |
Vol. 13 No. 3 |
244 |
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel |
Vol. 13 No. 3 |
245 |
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules |
Vol. 13 No. 3 |
246 |
Oxycodone Hydrochloride 20-mg Suppository |
Vol. 13 No. 3 |
247 |
Promethazine 20-mg and Acetaminophen 325-mg Suppositories |
Vol. 13 No. 3 |
248 |
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules |
Vol. 13 No. 3 |
249 |
Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel |
Vol. 13 No. 1 |
66 |
Tetracaine 0.025% Popsicles |
Vol. 13 No. 1 |
73 |
Equine Anesthesia: Triple Drip |
Vol. 12 No. 5 |
402 |
Aceclofenac 1.5% Gel-Cream |
Vol. 12 No. 5 |
446 |
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration |
Vol. 12 No. 5 |
463 |
Acetaminophen 10-mg/mL Rectal Solution |
Vol. 12 No. 5 |
447 |
Ketoprofen 20% Topical Solution |
Vol. 12 No. 5 |
452 |
Lidocaine Adhesive System Gel |
Vol. 12 No. 5 |
453 |
Piroxicam 5% and Dexpanthenol 5% Gel |
Vol. 12 No. 5 |
454 |
Case Reports: Compounding to Relieve Arthritis Pain |
Vol. 12 No. 6 |
498 |
Glycerin, Sterile |
Vol. 12 No. 6 |
542 |
Indomethacin 2% in Pluronic Lecithin Organogel |
Vol. 12 No. 6 |
543 |
Ketorolac Tromethamine 2% Topical Gel |
Vol. 12 No. 6 |
544 |
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel |
Vol. 12 No. 6 |
540 |
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel |
Vol. 12 No. 6 |
541 |
Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches |
Vol. 12 No. 6 |
549 |
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration |
Vol. 12 No. 6 |
553 |
Standard Operating Procedure: Dealing with Patients Experiencing Pain: Presenting without a Prescription |
Vol. 12 No. 3 |
259 |
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel |
Vol. 12 No. 3 |
266 |
PreScription: Pain! |
Vol. 12 No. 3 |
180 |
Topical Treatment of Neuropathic Pain |
Vol. 12 No. 3 |
182 |
Compounded Local Anesthetics to Minimize Pain from Medical Procedures |
Vol. 12 No. 3 |
192 |
Dilution and Compounding of Ziconotide for Intrathecal Administration |
Vol. 12 No. 3 |
200 |
Developing a Niche Marketing Strategy |
Vol. 12 No. 3 |
242 |
Chemical Stability of Tramadol Hydrochloride Injection |
Vol. 12 No. 2 |
161 |
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting |
Vol. 12 No. 2 |
163 |
Carbamazepine Topical Preparations |
Vol. 12 No. 2 |
150 |
Hospice and Compounding Pharmacy: Once Inseperable |
Vol. 12 No. 1 |
28 |
Diclofenac Sodium 1% Soft-Patch Gel |
Vol. 12 No. 1 |
65 |
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel |
Vol. 12 No. 1 |
66 |
Flosulide 10-mg/mL Injection |
Vol. 12 No. 1 |
69 |
Piroxicam 1% Soft-Patch Lipophilic Gel |
Vol. 12 No. 1 |
71 |
Piroxicam 1% Soft-Patch Topical Gel |
Vol. 12 No. 1 |
72 |
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen |
Vol. 11 No. 6 |
514 |
Lidocaine Hydrochloride 1.82% Buffered Injection |
Vol. 11 No. 6 |
511 |
Rabbit Medicine |
Vol. 11 No. 5 |
364 |
Diclofenac Sodium 75-mg/mL Injection |
Vol. 11 No. 5 |
421 |
Hydrocortisone 0.5% Ethanolic Gel |
Vol. 11 No. 5 |
423 |
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution |
Vol. 11 No. 4 |
328 |
Mebeverine Hydrochloride 20% gel |
Vol. 11 No. 4 |
330 |
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution |
Vol. 11 No. 4 |
335 |
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report |
Vol. 11 No. 3 |
212 |
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 |
Vol. 11 No. 3 |
220 |
Calculations - Compounding for Pain Management |
Vol. 11 No. 3 |
238 |
Transdermal Gel in the Treatment of Postoperative Pain |
Vol. 11 No. 3 |
181 |
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited |
Vol. 11 No. 3 |
187 |
The Rectal Rocket: A Two-Day Treatment for Hemorrhoids |
Vol. 11 No. 3 |
194 |
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain |
Vol. 11 No. 3 |
200 |
Levorphanol for the Treatment of Severe Chronic Pain |
Vol. 11 No. 3 |
202 |
Aspirin 80-mg/5-mL Oral Liquid, Anhydrous |
Vol. 11 No. 2 |
154 |
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster |
Vol. 11 No. 2 |
131 |
Principles of Pediatric Palliative Care and Pain Control |
Vol. 11 No. 1 |
10 |
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid |
Vol. 11 No. 1 |
71 |
Dexamethasone 1-mg/mL Oral Liquid |
Vol. 11 No. 1 |
72 |
Chloral Hydrate 50-mg/mL Oral Liquid |
Vol. 10 No. 6 |
453 |
Gabapentin 100-mg/mL Oral Liquid |
Vol. 10 No. 6 |
456 |
Indomethacin 2-mg/mL Oral Liquid |
Vol. 10 No. 6 |
458 |
Migraine: A General Approach to Prevention and Treatment |
Vol. 10 No. 5 |
344 |
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches |
Vol. 10 No. 5 |
351 |
Midazolam Hydrochloride 1-mg/mL Oral Liquid |
Vol. 10 No. 5 |
387 |
Hospice Symptom Relief Kit: An Update |
Vol. 10 No. 4 |
288 |
Tramadol Hydrochloride 5-mg/mL Oral Liquid |
Vol. 10 No. 4 |
307 |
Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid |
Vol. 10 No. 4 |
308 |
Mexiletine Hydrochloride 10-mg/mL Oral Suspension |
Vol. 10 No. 3 |
225 |
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together |
Vol. 10 No. 3 |
237 |
Chemical Stability of Diclofenac Sodium Injection |
Vol. 10 No. 2 |
154 |
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol |
Vol. 10 No. 2 |
159 |
Hospice from a Compounding Pharmacist's Perspective |
Vol. 10 No. 2 |
89 |
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh |
Vol. 10 No. 1 |
9 |
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery |
Vol. 10 No. 1 |
14 |
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid |
Vol. 10 No. 1 |
66 |
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management |
Vol. 10 No. 1 |
69 |
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags |
Vol. 9 No. 6 |
482 |
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain |
Vol. 9 No. 5 |
339 |
Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain |
Vol. 9 No. 5 |
349 |
A Patient's Guide to Transdermal Treatment of Pain |
Vol. 9 No. 5 |
354 |
Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules |
Vol. 9 No. 5 |
386 |
Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules |
Vol. 9 No. 5 |
387 |
Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules |
Vol. 9 No. 5 |
388 |
Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules |
Vol. 9 No. 5 |
389 |
Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection |
Vol. 9 No. 5 |
390 |
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules |
Vol. 9 No. 5 |
391 |
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules |
Vol. 9 No. 5 |
392 |
Methadone Hydrochloride 0.33-mg/mL Oral Solution |
Vol. 9 No. 5 |
393 |
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection |
Vol. 9 No. 5 |
394 |
Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) |
Vol. 9 No. 5 |
395 |
Bonain's Solution |
Vol. 9 No. 4 |
311 |
Brompton's Mixture |
Vol. 9 No. 4 |
312 |
Dexamethasone Oral Powder 10-mg Units, Veterinary |
Vol. 9 No. 3 |
226 |
Dipyrone 500-mg/mL Injection, Veterinary |
Vol. 9 No. 3 |
227 |
Meloxicam 0.2 mg/mL Oral Liquid, Veterinary |
Vol. 9 No. 3 |
228 |
Piroxicam 2-mg/mL Oral Liquid, Veterinary |
Vol. 9 No. 3 |
234 |
Capsaicin 0.2-mg Troches |
Vol. 9 No. 2 |
148 |
Clobetasol and Dyclonine Oral Paste |
Vol. 9 No. 2 |
150 |
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride |
Vol. 9 No. 2 |
157 |
Amitriptyline Hydrochloride 10-mg/mL Injection |
Vol. 9 No. 1 |
62 |
Fentanyl 15-mg/mL Injection, Preservative Free |
Vol. 9 No. 1 |
63 |
Gabapentin 2-mg/mL Injection, Preservative Free |
Vol. 9 No. 1 |
64 |
Lidocaine Hydrochloride-2%, Ketolorac Tromethamine-3%, and Clonidine Hydrochloride-0.1% Injection |
Vol. 9 No. 1 |
66 |
Naproxen Sodium 100-mg/mL Injection |
Vol. 9 No. 1 |
68 |
Phenol 8% Injection |
Vol. 9 No. 1 |
69 |
Tolazoline Hydrochloride 25-mg/mL Injection |
Vol. 9 No. 1 |
70 |
Tramadol Hydrochloride 50-mg/mL Injection, Preservative Free |
Vol. 9 No. 1 |
71 |
Compounding for Sports Medicine |
Vol. 8 No. 6 |
443 |
Diclofenac Sodium 25-mg/mL Injection |
Vol. 8 No. 6 |
470 |
Ketamine Hydrochloride and Fentanyl Citrate Injection |
Vol. 8 No. 6 |
474 |
Ketamine 25-mg/mL Nasal Spray |
Vol. 8 No. 6 |
475 |
Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray |
Vol. 8 No. 6 |
476 |
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink |
Vol. 8 No. 6 |
489 |
Book and Literature Reviews |
Vol. 8 No. 5 |
324 |
Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications |
Vol. 8 No. 5 |
337 |
Diclofenac Sodium 1.5% Topical Gel |
Vol. 8 No. 5 |
387 |
Ibuprofen 2% Topical Gel |
Vol. 8 No. 5 |
388 |
Book and Literature Reviews |
Vol. 8 No. 4 |
244 |
Migraine Headache Suppositories |
Vol. 8 No. 3 |
184 |
Dicyclomine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches |
Vol. 8 No. 3 |
184 |
Morphine Sulfate 5-mg/0.1-mL Nasal Spray |
Vol. 8 No. 3 |
185 |
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) |
Vol. 8 No. 3 |
185 |
Pain Management in the Elderly |
Vol. 8 No. 3 |
187 |
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medication Stick (Water-soluble base) |
Vol. 8 No. 3 |
208 |
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medications Stick (Water-proof base) |
Vol. 8 No. 3 |
208 |
Emollient Lip Balm with 5% Benzocaine |
Vol. 8 No. 3 |
208 |
Fever Blister Ointment |
Vol. 8 No. 3 |
208 |
Deoxy-D-Glucose 0.2%, Lidocaine HCl 5% and Sodium Lauryl Sulfate 5% Cream |
Vol. 8 No. 3 |
208 |
Acyclovir 5% and Lidocaine HCl 2% Topical Gel |
Vol. 8 No. 3 |
209 |
Acyclovir 5% and Sodium Lauryl Sulfate 5% Topical Gel |
Vol. 8 No. 3 |
209 |
Acyclovir 5% and Dexamethasone 0.1% Topical Gel |
Vol. 8 No. 3 |
209 |
Foscarnet 3% and Triamcinolone Acetonide 0.1% Topical Gel |
Vol. 8 No. 3 |
209 |
Clonidine HCl 1.5-mg/mL Injection |
Vol. 8 No. 3 |
216 |
Ketoprofen 50-mg Suppository |
Vol. 8 No. 3 |
219 |
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection |
Vol. 8 No. 3 |
220 |
Sumatriptan 25-mg Suppository |
Vol. 8 No. 3 |
221 |
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs |
Vol. 8 No. 2 |
101 |
Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection |
Vol. 8 No. 2 |
136 |
Sore Nipples in Breastfeeding Mothers: Causes and Treatments |
Vol. 7 No. 6 |
426 |
Methadone HCl 2.5-mg Capsules |
Vol. 7 No. 6 |
472 |
Tramadol HCl 100-mg Capsules |
Vol. 7 No. 6 |
475 |
Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers |
Vol. 7 No. 6 |
481 |
Indomethacin 50-mg Suppositories |
Vol. 7 No. 5 |
375 |
Pentazocine HCl 12.5-mg and Aspirin 325-mg Capsules |
Vol. 7 No. 5 |
377 |
Phenylbutazone 100-mg Capsules |
Vol. 7 No. 5 |
379 |
Basics of Compounding for Raynaud's Disease |
Vol. 7 No. 4 |
288 |
Meperidine HCl 100-mg/mL and Atropine Sulfate 0.4-mg/mL Injection |
Vol. 7 No. 4 |
300 |
Meperidine HCl 25-mg/mL and Promethazine HCl 25-mg/mL Injection |
Vol. 7 No. 4 |
301 |
Methocarbamol 400-mg and Aspirin 325-mg Capsules |
Vol. 7 No. 4 |
302 |
The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP |
Vol. 7 No. 3 |
180 |
Dexamethasone Phosphate 0.1% Topical Cream |
Vol. 7 No. 3 |
216 |
Ergotamine Tartrate 2-mg Sublingual Tablets |
Vol. 7 No. 3 |
219 |
Methadone HCl 5-mg/mL Injection |
Vol. 7 No. 3 |
221 |
Ketoprofen 10% in PLO |
Vol. 7 No. 3 |
183 |
Ketamine 10 %, Gabapentin 6%, and Nifedipine 2% in PLO |
Vol. 7 No. 3 |
171 |
PostScription: Sterile Product Admixture Preparation |
Vol. 7 No. 2 |
160 |
Dexamethasone Sodium Phosphate 4-mg/mL Injection |
Vol. 6 No. 6 |
450 |
Hydromorphone HCl 0.1-mg/mL Injection for Patient-Controlled Analgesia |
Vol. 6 No. 6 |
454 |
Methadone HCl 1-mg/mL, 2-mg/mL, and 5-mg/mL Injection |
Vol. 6 No. 6 |
455 |
Morphine Sulfate 2-mg/mL and Droperidol 0.08-mg/mL Injection for Patient-Controlled Analgesia |
Vol. 6 No. 6 |
456 |
Drug Therapy for Acute and Chronic Pain in the Cat |
Vol. 6 No. 5 |
338 |
Basics of Compounding: Phonophoresis |
Vol. 6 No. 5 |
362 |
Ketoprofen 2% Gel for Phonophoresis |
Vol. 6 No. 5 |
364 |
Naproxen 5% Gel for Phonophoresis |
Vol. 6 No. 5 |
364 |
Sodium Salicylate 10% Gel for Phonophoresis |
Vol. 6 No. 5 |
364 |
Hydrocortisone 10% Gel for Phonophoresis |
Vol. 6 No. 5 |
364 |
Dexamethasone 1.5% and Lidocaine HCl 4% Ultrasound Gel |
Vol. 6 No. 5 |
365 |
Ketoprofen 10% in Pluronic Lecithin Organogel |
Vol. 6 No. 5 |
368 |
Basics of Compounding for Iontophoresis, Part II |
Vol. 6 No. 4 |
288 |
Lidocaine HCl 4% Solution for Iontophoresis |
Vol. 6 No. 4 |
290 |
Dexamethasone 4-mg/mL Solution for Iontophoresis |
Vol. 6 No. 4 |
290 |
Acetic Acid 2% Solution for Iontophoresis |
Vol. 6 No. 4 |
290 |
Ketorolac 6-mg/mL Solution for Iontophoresis |
Vol. 6 No. 4 |
291 |
Treatment of Pain with a Topically Applied Combination of Indomethacin and Piroxicam |
Vol. 6 No. 3 |
189 |
Basics of Compounding: Iontophoresis, Part 1 |
Vol. 6 No. 3 |
194 |
Camphor, Menthol, and Eucalyptol Rubefacient Ointment |
Vol. 6 No. 3 |
201 |
Ergoloid Mesylates 15-mg/mL and Selegiline HCl 6.25-mg/mL in PLO |
Vol. 6 No. 3 |
203 |
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance |
Vol. 6 No. 1 |
4 |
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective |
Vol. 6 No. 1 |
13 |
Excerpts from and Reviews of Current Published Literature: Pain Management and Disorders of the Oral Cavity |
Vol. 6 No. 1 |
19 |
Analgesic NSAID Suppositories |
Vol. 6 No. 1 |
40 |
Capsaicin 0.075% Topical Spray |
Vol. 6 No. 1 |
41 |
Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO) |
Vol. 6 No. 1 |
42 |
Diltiazem HCl 2% Topical Gel |
Vol. 6 No. 1 |
43 |
Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection |
Vol. 6 No. 1 |
44 |
Fentanyl 100-mcg/0.1-mL in a Pluronic Lecithin Organogel (PLO) |
Vol. 6 No. 1 |
45 |
Ketoprofen 12.5-mg, Phenyltoloxamine Citrate 30-mg, and Caffeine 30-mg Capsules |
Vol. 6 No. 1 |
46 |
Morphine Sulfate 0.01%-Infused Silver Sulfadiazine (MISS) Cream |
Vol. 6 No. 1 |
47 |
Morphine Sulfate 5-mg/0.1-mL Nasal Spray |
Vol. 6 No. 1 |
48 |
Oxycodone 25-mg Slow-Release Capsules |
Vol. 6 No. 1 |
49 |
Hydrocortisone 10% Phonophoresis Gel |
Vol. 5 No. 6 |
454 |
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution |
Vol. 5 No. 6 |
455 |
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release |
Vol. 5 No. 5 |
401 |
Sclerotherapy Injections of Phenol for Pain Management |
Vol. 5 No. 4 |
308 |
PostScription: Case Reports and Formulations, George Roentsch, RPh. |
Vol. 5 No. 2 |
160 |
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel |
Vol. 5 No. 1 |
44 |
Fentanyl Troche Protocol |
Vol. 4 No .6 |
447 |
Capsicum Oleoresin 0.3% and Ketoprofen 10% in PLO Gel |
Vol. 4 No. 5 |
377 |
Ketamine for Pain in Hospice Patients |
Vol. 4 No. 4 |
253 |
Custom-Making Medications for the Hospice Patient |
Vol. 4 No. 4 |
255 |
Surviving Cancer - How the Compounding Pharmacist Can Help |
Vol. 4 No. 4 |
257 |
Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO |
Vol. 4 No. 4 |
299 |
Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution |
Vol. 4 No. 4 |
300 |
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers |
Vol. 4 No. 4 |
301 |
Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection |
Vol. 4 No. 4 |
303 |
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs |
Vol. 4 No. 4 |
318 |
Ketamine HCl 5% and Amitriptyline HCl 2% in PLO |
Vol. 4 No. 2 |
132 |
Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO |
Vol. 4 No. 2 |
133 |
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium |
Vol. 4 No. 1 |
6 |
The Psychology of Pain |
Vol. 4 No. 1 |
12 |
Opioids: A Review of the Pharmacology |
Vol. 4 No. 1 |
17 |
Fibromyalgia |
Vol. 4 No. 1 |
21 |
Compounding Intrathecal Medications |
Vol. 4 No. 1 |
24 |
Postherpetic Neuralgia |
Vol. 4 No. 1 |
27 |
Amitriptyline HCl 2% and Baclofen 2% in PLO |
Vol. 4 No. 1 |
50 |
Capsaicin 0.075%, Ketamine HCl 2% and Ketoprofen 10% in PLO |
Vol. 4 No. 1 |
51 |
Capsicum 0.32%, Methyl Salicylate 25% and Menthol 10% Analgesic Cream |
Vol. 4 No. 1 |
52 |
Clonidine HCl 1-mg/g in VanPen Cream |
Vol. 4 No. 1 |
53 |
Cyclobenzaprine 1% and Guaifenesin 10% in Speed Gel |
Vol. 4 No. 1 |
54 |
Dyclonine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches |
Vol. 4 No. 1 |
55 |
Fentanyl 50-mcg Chewable Gummy Gels |
Vol. 4 No. 1 |
56 |
Fentanyl 25-mcg/0.1-mL Nasal Spray |
Vol. 4 No. 1 |
57 |
Morphine Sulfate 2.5-mg/mL Inhalation Solution |
Vol. 4 No. 1 |
58 |
Shingles Ointment/Cream |
Vol. 4 No. 1 |
59 |
Osteoarthritis: Other Options |
Vol. 3 No. 6 |
433 |
Case Report: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player |
Vol. 3 No. 6 |
441 |
Case Reports: Iontophoresis and Phonophoresis for Treating Epicondylitis |
Vol. 3 No. 6 |
441 |
Capsicum and Capsaicin Formulas |
Vol. 3 No. 6 |
468 |
DMSO 70% Topical Solution |
Vol. 3 No. 6 |
469 |
Glucosamine HCl 600-mg Capsules |
Vol. 3 No. 6 |
470 |
Indomethacin 4% Topical Spray |
Vol. 3 No. 6 |
471 |
Iontophoresis Solutions for Arthritis |
Vol. 3 No. 6 |
472 |
Ketoprofen 2.5% in Pluronic Lecithin Organogel |
Vol. 3 No. 6 |
473 |
Methyl Salicylate and Menthol Analgesic Stick |
Vol. 3 No. 6 |
475 |
Piroxicam 1% Alcoholic Gel |
Vol. 3 No. 6 |
476 |
Ultrasonic Preparations for Arthritis |
Vol. 3 No. 6 |
477 |
Compounding for Athletes: Successful Sports Compounds |
Vol. 3 No. 5 |
382 |
The Basics of Compounding: Compounding Gels |
Vol. 3 No. 5 |
385 |
Piroxicam 0.5% in an Alcoholic Gel |
Vol. 3 No. 5 |
389 |
Pluronic Lecithin Organogel (PLO Gel) |
Vol. 3 No. 5 |
389 |
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules |
Vol. 3 No. 5 |
409 |
Fentanyl 20-mcg/mL and Bupivacaine HCl 1.25-mg/mL for Pump Administration |
Vol. 3 No. 4 |
301 |
Morphine Sulfate 50-mg/mL Injection |
Vol. 3 No. 4 |
302 |
Rapid Pharmacokinetic Evaluation of Topical Drug Formulations |
Vol. 3 No. 4 |
321 |
Compounding for Athletes: Tips for Making the Team |
Vol. 3 No. 3 |
206 |
Morphine Sulfate-Dextromethorphan Hydrobromide-Example of capsule with Dry Powder Fill |
Vol. 3 No. 3 |
215 |
Compounding for Athletes: A Primer for Rookies |
Vol. 3 No. 2 |
104 |
The Basics of Compounding: Compounding Creams and Lotions |
Vol. 3 No. 2 |
111 |
Athletic-Analgesic Rub |
Vol. 3 No. 2 |
130 |
Piroxicam 0.5% in Pluronic Lecithin Organogel |
Vol. 3 No. 2 |
133 |
The Basics of Compounding: Compounding Ointments and Pastes |
Vol. 3 No. 1 |
22 |
Topical Ketoprofen for Fibromyalgia |
Vol. 2 No. 6 |
433 |
Ketorolac tromethamine and Ketoprofen suppositories: release profiles and bioavailability of cocoa butter base formula in rabbits |
Vol. 2 No. 5 |
390 |
Antipruritus Suspension (Stop Itch) |
Vol. 2 No. 4 |
277 |
Benzocaine 2% Anesthetic Gel |
Vol. 2 No. 4 |
296 |
Cocaine-Phenol-Tannic Acid Ointment |
Vol. 2 No. 4 |
298 |
Compounding for Pain Management |
Vol. 2 No. 2 |
104 |
Opioids for Noncancer Pain: From Controversy to Consensus |
Vol. 2 No. 2 |
106 |
Phonophoresis with Hydrocortisone 10% in a Highly Viscous Complant Base |
Vol. 2 No. 2 |
110 |
Managing Pain in the Terminally Ill |
Vol. 2 No. 2 |
111 |
The Symptom Relief Kit for Hospice Patients |
Vol. 2 No. 2 |
116 |
Dextromethorphan Hydrobromide and Opioid Tolerance: A Compounding Opportunity for Pharmacists with Chronic Pain Patients |
Vol. 2 No. 2 |
118 |
Profile of a Practice/Patient Handout: DHE Nasal Spray |
Vol. 2 No. 2 |
120 |
Clinical Application of Ketamine Ointment in the Treatment of Sympathetically Maintained Pain |
Vol. 2 No. 2 |
122 |
Buprenorphine HCl 150-mcg/100 mcL Nasal Spray |
Vol. 2 No. 2 |
145 |
Capsaicin 0.05% Topical Gel |
Vol. 2 No. 2 |
146 |
Dexamethasone Sodium Phosphate 1-mg/mL for Iontophoresis |
Vol. 2 No. 2 |
147 |
Dextromethorphan Hydrobromide 30-mg and Morphine Sulfate 10-mg Capsules |
Vol. 2 No. 2 |
148 |
Dihydroergotamine Mesylate 2.5-mg/mL Nasal Spray |
Vol. 2 No. 2 |
149 |
Dihydroergotamine Mesylate 1-mg Troches |
Vol. 2 No. 2 |
150 |
Ergotamine Tartrate, Caffeine, Hyoscyamine Sulfate and Pentobarbital Sodium Suppositories |
Vol. 2 No. 2 |
151 |
Fentanyl 50-mcg Chewable Gummy Gels |
Vol. 2 No. 2 |
152 |
Fentanyl 300-mcg/6-mL Inhalation |
Vol. 2 No. 2 |
153 |
Ketoprofen 10%, Cyclobenzaprine 1% and Lidocaine 5% in Poloxamer Lecithin Organogel |
Vol. 2 No. 2 |
154 |
Lidocaine 30% Lip Balm |
Vol. 2 No. 2 |
155 |
Meperidine HCl 50-mg/mL Nasal Solution |
Vol. 2 No. 2 |
156 |
Morphine Sulfate 25-mg Troche |
Vol. 2 No. 2 |
157 |
Sumatriptan 5-mg/mL Oral Liquid |
Vol. 2 No. 2 |
158 |
Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel |
Vol. 2 No. 2 |
159 |
Dexamethasone and Lidocaine Solution for Iontophoresis |
Vol. 1 No. 6 |
410 |
Ketorolac Solution for Iontophoresis |
Vol. 1 No. 6 |
415 |
Lidocaine HCl 2% Solution for Iontophoresis |
Vol. 1 No. 6 |
416 |
Morphine 10-mg Troches |
Vol. 1 No. 6 |
417 |
Iontophoresis Devices: Clinical Applications for Topical Delivery |
Vol. 1 No. 6 |
420 |
Fentanyl-Bupivacaine-Epinephrine for Epidural Analgesia |
Vol. 1 No. 5 |
325 |
Hydromorphone HCl 10-, 25-, and 50-mg/mL Injections |
Vol. 1 No. 5 |
327 |
Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection |
Vol. 1 No. 5 |
328 |
Morphine Sulfate-Bupivacaine HCl Injection |
Vol. 1 No. 5 |
330 |
Morphine Sulfate 10-, 25-, and 50-mg/mL Injections (Preservative Free) |
Vol. 1 No. 5 |
331 |
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease |
Vol. 1 No. 4 |
242 |
Beclomethasone Dipropionate 1.25 mg/mL Aerosol Solution-Veterinary |
Vol. 1 No. 4 |
243 |
Fentanyl and Bupivacaine Injection for Ambulatory Pump Reservoir |
Vol. 1 No. 3 |
178 |
Piroxicam 2% in an Alcoholic Gel |
Vol. 1 No. 3 |
181 |
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections |
Vol. 1 No. 3 |
206 |
Rectal and Stomal Administration of Analgesic Suppositories |
Vol. 1 No. 1 |
12 |
Morphine Sulfate Slow-Release Suppositories |
Vol. 1 No. 1 |
32 |
Morphine Suppositories |
Vol. 1 No. 1 |
36 |